by Five Rivers Rx | Aug 12, 2020 | Industry News, Regulations
The DSCSA has had wide-ranging implications on state regulation of the pharmaceutical supply chain. But are some states using it as an opportunity to increase their oversight which has resulted in onerous requirements for the industry? Background In early 2019,...
by Five Rivers Rx | Jul 30, 2020 | Industry News, Regulations
The patchwork that is state licensure is a constant challenge for all companies in the pharmaceutical supply chain – from international drug manufacturers to independent distributors. Companies not in compliance are at significant risk of being caught by state...
by Five Rivers Rx | Jul 16, 2020 | Regulations, Uncategorized
State regulation of the pharmaceutical supply chain is a patchwork of different definitions, requirements, and enforcement– will this FDA proposed rule finally bring uniformity? Background The Drug Supply Chain Security Act (DSCSA), signed into law by President Obama...
by Five Rivers Rx | Jul 2, 2020 | Suspicious Order Monitoring
Background In July 2016, at the height of the opioid epidemic, the West Virginia Attorney General’s Office and the West Virginia Board of Pharmacy came together to develop a calculator that converts opioid dosage amounts to a standard, comparable measurement. The...
by Five Rivers Rx | Jun 18, 2020 | VAWD
Two separate PBMs recently issued audits to an independent pharmacy because it was determined that the pharmacy was sourcing diverted test strips from an NABP DDA (fka VAWD®) Accredited facility. Against the backdrop of the controversial policy by Optum Rx which...
